Essential 8 Media System
Just what stem cells need.
Nothing they don’t.
Starting with the original formulation, Gibco Essential 8 Medium is our most defined and consistent feeder-free medium for induced pluripotent stem cell culture. It has been optimized for a wide variety of applications to help researchers achieve ultimate control over their PSC culture systems.
Gibco PSC Media are manufactured according to cGMP for medical devices, 21 CFR Part 820
Where do you need more control over your PSC Culture?
Support through stressful events
|PSC maintenance and expansion||Essential 8 Medium||
|Flexible feeding schedule||Essential 8 Flex Medium||
|Differentiation||Essential 6 Medium||
||Essential 8 Medium + RevitaCell Supplement||
|Adaptation from feeder-based media||Essential 8
|Transition from bench to clinical research
||CTS Essential 8 Medium||
Non-addictive – Shown to have a non-addictive impact on downstream cell utility unlike other ROCK inhibitors
Expanded applications – Enabling use of Essential 8 medium in applications where cells need additional support
The Essential 8 Media system and accompanying reagents provide the most defined and consistent culture conditions for pluripotent stem cells. Each of the recommended reagents across the following workflow is defined and xenofree, allowing for consistent results every time. Below is an example of a workflow advancing from reprogramming to differentiation utilizing the Essential 8 Media system.
CytoTune-iPS 2.0 Sendai Reprogramming Kit
contains a polycistronic vector which offers an increased reprogramming efficiency up to 1.2%
Essential 8 Medium contains only the 8 necessary components needed for stem cell culture enabling more consistent culture
PSC Cryopreservation Kit contains a xeno-free, ready-to-use cryopreservation medium and a chemically defined recovery supplement, RevitaCell Supplement, that consistently recovers 50% more viable cells post-thaw
For research use only. Not for use in diagnostic procedures. Essential 8 and Essential 6 are trademarks of Cellular Dynamics International, Inc.